Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older Adults: The Rancho Bernardo Study

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Circulation

• Publication date

  2011-05-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.110.979740PMID 21536998PMCID PMC3107013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

  2011cited by this paper
• Growth Differentiation Factor-15 and Risk of Recurrent Events in Patients Stabilized After Acute Coronary Syndrome: Observations From PROVE IT-TIMI 22

  2011cited by this paper
• Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study.

  2009cited by this paper
• Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association

  2009cited by this paper
• Elevated levels of MIC‐1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome

  2009cited by this paper
• Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.

  2009cited by this paper
• Macrophage inhibitory cytokine-1 is overexpressed in malignant melanoma and is associated with tumorigenicity.

  2009cited by this paper
• Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer

  2009cited by this paper
• Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study

  2009cited by this paper
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

  2008cited by this paper
• Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.

  2007cited by this paper
• Prognostic Value of Growth-Differentiation Factor-15 in Patients With Non–ST-Elevation Acute Coronary Syndrome

  2007cited by this paper
• Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction.

  2007cited by this paper
• Concordance for Survival Time Data: Fixed and Time-Dependent Covariates and Possible Ties in Predictor and Time

  2007cited by this paper
• Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer.

  2006cited by this paper
• The Transforming Growth Factor-&bgr; Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion Injury

  2006cited by this paper
• GDF15/MIC-1 Functions As a Protective and Antihypertrophic Factor Released From the Myocardium in Association With SMAD Protein Activation

  2006cited by this paper
• The Transforming Growth Factor-β Family Members Bone Morphogenetic Protein-2 and Macrophage Inhibitory Cytokine-1 as Mediators of the Antiangiogenic Activity of N-(4-Hydroxyphenyl)Retinamide

  2005cited by this paper
• GROWTH DIFFERENTIATION FACTOR-15/MACROPHAGE INHIBITORY CYTOKINE-1 INDUCTION AFTER KIDNEY AND LUNG INJURY

  2005cited by this paper
• IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW，Thompson RW，et al//Proc Natl Acad Sci U S A

  2005cited by this paper
• Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions

  2004cited by this paper
• Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers

  2004cited by this paper
• A gene atlas of the mouse and human protein-encoding transcriptomes.

  2004cited by this paper
• Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.

  2003cited by this paper
• Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

  2003cited by this paper
• MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma.

  2003cited by this paper
• Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation.

  2002cited by this paper
• Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study.

  2002cited by this paper
• MIC‐1 is a novel TGF‐β superfamily cytokine associated with macrophage activation

  1999cited by this paper
• A Simplified Method of Calculating an Overall Goodness-of-Fit Test for the Cox Proportional Hazards Model

  1998cited by this paper
• MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily.

  1997cited by this paper
• Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta.

  1997cited by this paper
• The Importance of Cardiovascular Risk Factors in the Elderly.

  1995cited by this paper
• The Clinical Perspective

  1994cited by this paper
• The hypertension detection and follow-up program.

  1984cited by this paper
• The hypertension detection and follow-up program.

  1984cited by this paper
• The analysis of failure times in the presence of competing risks.

  1978cited by this paper
• The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group.

  1976cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Impacts of systemic milieu on cerebrovascular and brain aging: insights from heterochronic parabiosis, blood exchange, and plasma transfer experiments

  2025cites this paper
• A Multicenter Study for Establishing Reference Intervals of Serum GDF-15 Levels Based on the Chinese Population

  2025cites this paper
• Prediction of Japan Score and Society of Thoracic Surgeons Risk Scores for Patients Undergoing Cardiovascular Surgery by Serum Growth Differentiation Factor-15 and Endothelin-1 Levels

  2025cites this paper
• Association between dietary patterns and chronic kidney disease in elderly patients with type 2 diabetes: a community-based cross-sectional study

  2025cites this paper
• Geroscience in heart failure: the search for therapeutic targets in the shared pathobiology of human aging and heart failure

  2025cites this paper
• Molecular Phenogroups in Heart Failure: Large-Scale Proteomics in a Population-Based Cohort

  2025cites this paper
• Growth differentiation factor 15 predicts physical function impairment in Spanish older adults: a real-world prospective study.

  2025cites this paper
• Appetite loss as a clinical marker of loss of function during aging.

  2025cites this paper
• Circulating cardiovascular biomarkers in motion: redefining cardiovascular risk with dynamic prediction.

  2025cites this paper
• Metabolic Messenger: growth differentiation factor 15

  2025cites this paper
• Serum Proteomic and Metabolomic Signatures of High Versus Low Physical Function in Octogenarians

  2025cites this paper
• Inflammatory and vascular biomarkers as predictors of all‐cause death and cardiovascular outcomes in an Australian community‐based cohort

  2025cites this paper
• Age‐Associated Increase in Growth Differentiation Factor 15 Levels Correlates With Central Arterial Stiffness and Predicts All‐Cause Mortality in a Sardinian Population Cohort

  2025cites this paper
• Circulating Mitokines GDF-15 and FGF21 are associated with Frailty, Sarcopenia, and Malnutrition in Older Adults: Evidence from the FRASNET Study.

  2025cites this paper
• Sex Differences in the Prognostic Value of Circulating Biomarkers in Patients Presenting With Acute Chest Pain

  2025cites this paper
• Physiological Role of Serum Growth Differentiation Factor-15 (GDF-15) Level and Iron Metabolism in Community-Dwelling Older Adults

  2024cites this paper
• Growth differentiation factor 15 (GDF15) levels are associated with malnutrition in acutely admitted older adults.

  2024cites this paper
• Influence of combined high-intensity interval training and green tea extract on cardiac stress markers and insulin resistance in obese men with type 2 diabetes: a randomized double-blind placebo-controlled trial

  2024cites this paper
• Health implications of racial differences in serum growth differentiation factor levels among men with obesity

  2024cites this paper
• The relationship of growth differentiation factor 15 with some biochemical parameters in cardiovascular disease patients in Babylon City

  2024cites this paper
• Growth Differentiation Factor 15 and diet quality trajectory interact to determine frailty incidence among middle-aged urban adults.

  2024cites this paper
• Identifying proteins and pathways associated with multimorbidity in 53,026 adults.

  2024cites this paper
• Inflammation in heart failure: pathophysiology and therapeutic strategies

  2024cites this paper
• Associations of Serum GDF-15 Levels with Physical Performance, Mobility Disability, Cognition, Cardiovascular Disease, and Mortality in Older Adults

  2024cites this paper
• The GDF15 3′ UTR Polymorphism rs1054564 Is Associated with Diabetes and Subclinical Atherosclerosis

  2024cites this paper
• Identification of Growth Differentiation Factor-15 as An Early Predictive Biomarker for Metabolic Dysfunction-Associated Steatohepatitis: A Nested Case-control Study of UK Biobank Proteomic Data

  2024cites this paper
• Growth differentiation factor-15 predicts all-cause death and major adverse cardiovascular events in patients with coronary heart disease: a prospective cohort study

  2024cites this paper
• Plasma proteomic profiles predict individual future health risk

  2023cites this paper
• Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis

  2023cites this paper
• Which biomarkers are predictive speci fi cally for cardiovascular or for non-cardiovascular mortality in men? Evidence from the Caerphilly Prospective Study (CaPS)

  2023cites this paper
• Intracellular to Interorgan Mitochondrial Communication in Striated Muscle in Health and Disease

  2023cites this paper
• Predictive Biochemical Model of Frailty and Mortality After Acute Myocardial Infarction.

  2023cites this paper
• GDF‐15 at admission predicts cardiovascular death, heart failure, and bleeding outcomes in patients with CAD

  2023cites this paper
• Biomarkers of Cardiovascular Disease and Future Directions: A Review

  2023cites this paper
• Association Between Serum GDF15 Concentration and Total Mortality in Community-Dwelling Japanese Older Populations: The Involvement of Renal Dysfunction.

  2023cites this paper
• Effect of age and gender on serum growth differentiation factor 15 and its relationship to bone density and bone turnover.

  2023cites this paper
• Association between a Mediterranean lifestyle and growth differentiation factor 15: The seniors ENRICA-2 cohort.

  2022cites this paper
• Growth differentiation factor-15 (GDF-15) predicts major bleeding, major adverse cardiac events, and mortality in patients with end-stage kidney disease on hemodialysis: findings from the VIVALDI study.

  2022cites this paper
• Relationship Between Plasma Growth Differentiation Factor 15 Levels and Complications of Type 2 Diabetes Mellitus: A Cross-sectional Study.

  2022cites this paper
• Cooking methods are associated with inflammatory factors, renal function, and other hormones and nutritional biomarkers in older adults

  2022cites this paper
• Growth Differentiation Factor 15 and the Subsequent Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study.

  2022cites this paper
• Umbilical cord plasma concentrate has beneficial effects on DNA methylation GrimAge and human clinical biomarkers

  2022cites this paper
• GDF15 and its association with cognitive performance over time in a longitudinal study of middle-aged urban adults.

  2022cites this paper
• Greenspace, Inflammation, Cardiovascular Health, and Cancer: A Review and Conceptual Framework for Greenspace in Cardio-Oncology Research

  2022influential citation
• Relationship between the serum GDF-15 concentration and muscle function in female patients receiving aortic valve replacement (TAVR, SAVR): Comparison with healthy elderly female subjects

  2022cites this paper
• Serum markers of biological ageing provide long-term prediction of life expectancy-a longitudinal analysis in middle-aged and older German adults.

  2022cites this paper
• Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future

  2022cites this paper
• Associations of device‐measured sleep, sedentariness and physical activity with growth differentiation factor 15 in older adults

  2022cites this paper
• Alcohol consumption patterns and growth differentiation factor 15 among lifetime drinkers aged 65+ years in Spain: a cross-sectional study.

  2022cites this paper
• Role of circulating molecules in age-related cardiovascular and metabolic disorders

  2022cites this paper
• Deletion of Gdf15 reduces ER stress-induced beta cell apoptosis and diabetes.

  2022cites this paper
• Serum GDF-15 Predicts In-Hospital Mortality and Arrhythmic Risks in Patients With Acute Myocardial Infarction

  2022cites this paper
• Association between serum GDF-15, myostatin, and sarcopenia in cardiovascular surgery patients

  2022cites this paper
• A Golden Age of Aging Biomarker Discovery

  2022cites this paper
• Characterization of atherosclerotic plaques in blood vessels with low oxygenated blood and blood pressure (Pulmonary trunk): role of growth differentiation factor-15 (GDF-15)

  2021cites this paper
• Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease

  2021cites this paper
• Protective Effects of Silymarin Against D-Gal/LPS-Induced Organ Damage and Inflammation in Mice

  2021cites this paper
• Association of serum growth differentiation factor-15 levels with the risks of death and vascular events in patients with ischemic stroke: The role of diabetes.

  2021cites this paper
• Ageing-related markers and risks of cancer and cardiovascular disease: a prospective study in the EPIC-Heidelberg cohort

  2021cites this paper
• Longitudinal course of GDF15 levels before acute hospitalization and death in the general population

  2021cites this paper
• Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans

  2021cites this paper
• Growth differentiation factor-15 predicts major adverse cardiac events and all-cause mortality in patients with atrial fibrillation.

  2021cites this paper
• GDF-15 como Biomarcador em Doenças Cardiovasculares

  2021cites this paper
• Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality

  2021cites this paper
• Growth Differentiation Factor (GDF)-15 and Cardiometabolic Outcomes among Older Adults: The Atherosclerosis Risk in Communities Study.

  2021cites this paper
• Cardiovascular disease related circulating biomarkers and cancer incidence and mortality: is there an association?

  2021cites this paper
• GDF-15 as a Biomarker in Cardiovascular Disease

  2021cites this paper
• Associations between elevated growth differentiation factor-15 and sarcopenia among community-dwelling older adults.

  2021cites this paper
• Role of novel biomarkers in diabetic cardiomyopathy

  2021cites this paper
• IGFBP7 and GDF-15, but not P1NP, are associated with cardiac alterations and 10-year outcome in an elderly community-based study

  2021cites this paper
• Association between Cardiorespiratory Fitness and Circulating Proteins in 50-Year-Old Swedish Men and Women: a Cross-Sectional Study

  2021cites this paper
• GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease.

  2021cites this paper
• Healthy dietary patterns are associated with lower concentrations of growth differentiation factor 15 in older adults.

  2021cites this paper
• Circulating Growth Differentiation Factor 15 Levels Are Associated With Risk of Both Intracerebral and Subarachnoid Hemorrhage

  2021cites this paper
• Protective Effects of Silymarin Against D-Gal/LPS-Induced Organ Damage and Inflammation in Mice

  2021cites this paper
• GDF15 and Cardiac Cells: Current Concepts and New Insights

  2021cites this paper
• Growth Differentiation Factor‐15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J‐HOP Study

  2021cites this paper
• Growth Differentiation Factor 15 Predicts Cancer Death in Patients With Cardiovascular Risk Factors: The J-HOP Study

  2021cites this paper
• The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality.

  2020cites this paper
• The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications

  2020cites this paper
• Increased Growth Differentiation Factor 15 in Patients with Hypoleptinemia-Associated Lipodystrophy

  2020cites this paper
• Growth differentiation factor‐15 is associated with age‐related monocyte dysfunction

  2020cites this paper
• Plasma growth differentiation factor 15 levels for predicting serious adverse events and bleeding in acute pulmonary embolism: a prospective observational study

  2020cites this paper
• Association between Growth Differentiation Factor 15 and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus

  2020cites this paper
• Functional roles of GDF15 in modulating microenvironment to promote carcinogenesis.

  2020cites this paper
• Cardiac Biomarkers and Risk of Mortality in CKD (the CRIC Study)

  2020cites this paper
• Growth Differentiation Factor-15 as a Potent Predictor of Long-Term Mortality among Subjects with Osteoarthritis

  2020cites this paper
• Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player

  2020cites this paper
• [Level of the growth differentiation factor-15 in patients with acute myocardial infarction].

  2020cites this paper
• The Biomarkers for Acute Myocardial Infarction and Heart Failure

  2020cites this paper
• Multimarker approach including CRP, sST2 and GDF‐15 for prognostic stratification in stable heart failure

  2020cites this paper
• Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes: a prospective study: Abbreviated title: GDF-15, all-cause mortality and CVD.

  2020cites this paper
• Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease

  2020cites this paper
• Plasma proteomic biomarker signature of age predicts health and life span

  2020cites this paper
• The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?

  2020cites this paper
• Growth differentiation factor-15 is associated with age-related monocyte immunosenescence

  2020cites this paper
• Novel biomarkers for prediction of outcome in hip fracture patients—An exploratory study

  2020cites this paper
• GDF-15 is associated×with sudden cardiac death due to incident myocardial infarction.

  2020cites this paper
• Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review.

  2020cites this paper
• Association between GDF15, poverty and mortality in urban middle-aged African American and white adults

  2020cites this paper